nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—ADRA1D—Amine ligand-binding receptors—HRH3—narcolepsy	0.0223	0.0223	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Other—P2RY11—narcolepsy	0.0209	0.0209	CbGpPWpGaD
Midodrine—ADRA1B—Amine ligand-binding receptors—HRH3—narcolepsy	0.0185	0.0185	CbGpPWpGaD
Midodrine—ADRA1B—AMPK Signaling—CPT1B—narcolepsy	0.0173	0.0173	CbGpPWpGaD
Midodrine—ADRA1A—Amine ligand-binding receptors—HRH3—narcolepsy	0.0164	0.0164	CbGpPWpGaD
Midodrine—ADRA1A—AMPK Signaling—CPT1B—narcolepsy	0.0153	0.0153	CbGpPWpGaD
Midodrine—ADRA1D—Monoamine GPCRs—HTR2A—narcolepsy	0.0132	0.0132	CbGpPWpGaD
Midodrine—ADRA1D—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0121	0.0121	CbGpPWpGaD
Midodrine—ADRA1D—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0121	0.0121	CbGpPWpGaD
Midodrine—ADRA1D—G alpha (q) signalling events—P2RY11—narcolepsy	0.0117	0.0117	CbGpPWpGaD
Midodrine—ADRA1D—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0111	0.0111	CbGpPWpGaD
Midodrine—ADRA1B—Monoamine GPCRs—HTR2A—narcolepsy	0.011	0.011	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0109	0.0109	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0109	0.0109	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0105	0.0105	CbGpPWpGaD
Midodrine—ADRA1B—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0101	0.0101	CbGpPWpGaD
Midodrine—ADRA1B—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0101	0.0101	CbGpPWpGaD
Midodrine—ADRA1D—G alpha (q) signalling events—HCRT—narcolepsy	0.00996	0.00996	CbGpPWpGaD
Midodrine—ADRA1A—Monoamine GPCRs—HTR2A—narcolepsy	0.00975	0.00975	CbGpPWpGaD
Midodrine—ADRA1B—G alpha (q) signalling events—P2RY11—narcolepsy	0.00973	0.00973	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00938	0.00938	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00938	0.00938	CbGpPWpGaD
Midodrine—ADRA1B—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00922	0.00922	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00906	0.00906	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.00901	0.00901	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00901	0.00901	CbGpPWpGaD
Midodrine—ADRA1A—G alpha (q) signalling events—HCRTR2—narcolepsy	0.00895	0.00895	CbGpPWpGaD
Midodrine—ADRA1A—G alpha (q) signalling events—HCRTR1—narcolepsy	0.00895	0.00895	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00891	0.00891	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0087	0.0087	CbGpPWpGaD
Midodrine—ADRA1A—G alpha (q) signalling events—P2RY11—narcolepsy	0.00864	0.00864	CbGpPWpGaD
Midodrine—ADRA1B—G alpha (q) signalling events—HCRT—narcolepsy	0.00827	0.00827	CbGpPWpGaD
Midodrine—ADRA1A—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00819	0.00819	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00804	0.00804	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00804	0.00804	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.008	0.008	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.008	0.008	CbGpPWpGaD
Midodrine—ADRA1B—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00778	0.00778	CbGpPWpGaD
Midodrine—ADRA1B—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00778	0.00778	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00776	0.00776	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00773	0.00773	CbGpPWpGaD
Midodrine—ADRA1D—G alpha (q) signalling events—TRH—narcolepsy	0.00755	0.00755	CbGpPWpGaD
Midodrine—ADRA1B—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00752	0.00752	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.0074	0.0074	CbGpPWpGaD
Midodrine—ADRA1A—G alpha (q) signalling events—HCRT—narcolepsy	0.00735	0.00735	CbGpPWpGaD
Midodrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00691	0.00691	CbGpPWpGaD
Midodrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00691	0.00691	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00675	0.00675	CbGpPWpGaD
Midodrine—ADRA1A—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00668	0.00668	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00667	0.00667	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00667	0.00667	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0066	0.0066	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00657	0.00657	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00644	0.00644	CbGpPWpGaD
Midodrine—ADRA1B—G alpha (q) signalling events—TRH—narcolepsy	0.00627	0.00627	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—HCRTR1—narcolepsy	0.00612	0.00612	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—HCRTR2—narcolepsy	0.00612	0.00612	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00592	0.00592	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00592	0.00592	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—P2RY11—narcolepsy	0.00591	0.00591	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00588	0.00588	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Other—HTR2A—narcolepsy	0.00587	0.00587	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00572	0.00572	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00561	0.00561	CbGpPWpGaD
Midodrine—ADRA1A—G alpha (q) signalling events—TRH—narcolepsy	0.00557	0.00557	CbGpPWpGaD
Midodrine—ADRA1D—G alpha (q) signalling events—TAC1—narcolepsy	0.00549	0.00549	CbGpPWpGaD
Midodrine—ADRA1D—G alpha (q) signalling events—NPS—narcolepsy	0.00549	0.00549	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00548	0.00548	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00512	0.00512	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—HCRTR2—narcolepsy	0.00508	0.00508	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—HCRTR1—narcolepsy	0.00508	0.00508	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—HCRT—narcolepsy	0.00503	0.00503	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.005	0.005	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00498	0.00498	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00491	0.00491	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00491	0.00491	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—P2RY11—narcolepsy	0.00491	0.00491	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00488	0.00488	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00487	0.00487	CbGpPWpGaD
Midodrine—ADRA1B—G alpha (q) signalling events—TAC1—narcolepsy	0.00455	0.00455	CbGpPWpGaD
Midodrine—ADRA1B—G alpha (q) signalling events—NPS—narcolepsy	0.00455	0.00455	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—HCRTR1—narcolepsy	0.00451	0.00451	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—HCRTR2—narcolepsy	0.00451	0.00451	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—PENK—narcolepsy	0.00448	0.00448	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00439	0.00439	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—P2RY11—narcolepsy	0.00436	0.00436	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00434	0.00434	CbGpPWpGaD
Midodrine—ADRA1B—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00425	0.00425	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—HCRT—narcolepsy	0.00417	0.00417	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00415	0.00415	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00407	0.00407	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00407	0.00407	CbGpPWpGaD
Midodrine—ADRA1A—G alpha (q) signalling events—TAC1—narcolepsy	0.00405	0.00405	CbGpPWpGaD
Midodrine—ADRA1A—G alpha (q) signalling events—NPS—narcolepsy	0.00405	0.00405	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—TRH—narcolepsy	0.00381	0.00381	CbGpPWpGaD
Midodrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00377	0.00377	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—PENK—narcolepsy	0.00372	0.00372	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—HCRT—narcolepsy	0.0037	0.0037	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00369	0.00369	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00364	0.00364	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00363	0.00363	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00363	0.00363	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00362	0.00362	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00362	0.00362	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—HCRTR2—narcolepsy	0.00346	0.00346	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—HCRTR1—narcolepsy	0.00346	0.00346	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—P2RY11—narcolepsy	0.00334	0.00334	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—HRH3—narcolepsy	0.00334	0.00334	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—PENK—narcolepsy	0.0033	0.0033	CbGpPWpGaD
Midodrine—ADRA1D—G alpha (q) signalling events—HTR2A—narcolepsy	0.0033	0.0033	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00323	0.00323	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—TRH—narcolepsy	0.00316	0.00316	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—HCRTR2—narcolepsy	0.00314	0.00314	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—HCRTR1—narcolepsy	0.00314	0.00314	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—P2RY11—narcolepsy	0.00303	0.00303	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00302	0.00302	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00302	0.00302	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00295	0.00295	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—HCRTR2—narcolepsy	0.00287	0.00287	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—HCRTR1—narcolepsy	0.00287	0.00287	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—HCRT—narcolepsy	0.00284	0.00284	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—TRH—narcolepsy	0.00281	0.00281	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—P2RY11—narcolepsy	0.00277	0.00277	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—HRH3—narcolepsy	0.00277	0.00277	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—TAC1—narcolepsy	0.00277	0.00277	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—NPS—narcolepsy	0.00277	0.00277	CbGpPWpGaD
Midodrine—ADRA1B—G alpha (q) signalling events—HTR2A—narcolepsy	0.00274	0.00274	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00268	0.00268	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00268	0.00268	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—HCRTR2—narcolepsy	0.00261	0.00261	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—HCRTR1—narcolepsy	0.00261	0.00261	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—HCRT—narcolepsy	0.00258	0.00258	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00255	0.00255	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00255	0.00255	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00255	0.00255	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—PENK—narcolepsy	0.00253	0.00253	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—P2RY11—narcolepsy	0.00252	0.00252	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—P2RY11—narcolepsy	0.00246	0.00246	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—HRH3—narcolepsy	0.00246	0.00246	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00245	0.00245	CbGpPWpGaD
Midodrine—ADRA1A—G alpha (q) signalling events—HTR2A—narcolepsy	0.00243	0.00243	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—HCRT—narcolepsy	0.00236	0.00236	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—HCRTR2—narcolepsy	0.00232	0.00232	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—HCRTR1—narcolepsy	0.00232	0.00232	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—PENK—narcolepsy	0.0023	0.0023	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—NPS—narcolepsy	0.0023	0.0023	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—TAC1—narcolepsy	0.0023	0.0023	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—P2RY11—narcolepsy	0.00224	0.00224	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00219	0.00219	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00218	0.00218	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—TRH—narcolepsy	0.00215	0.00215	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—HCRT—narcolepsy	0.00214	0.00214	CbGpPWpGaD
Midodrine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00212	0.00212	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—PENK—narcolepsy	0.0021	0.0021	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—HCRT—narcolepsy	0.00209	0.00209	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—NPS—narcolepsy	0.00204	0.00204	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—TAC1—narcolepsy	0.00204	0.00204	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—TRH—narcolepsy	0.00195	0.00195	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—PENK—narcolepsy	0.00191	0.00191	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—HCRT—narcolepsy	0.0019	0.0019	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—HRH3—narcolepsy	0.00189	0.00189	CbGpPWpGaD
Midodrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00188	0.00188	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—PENK—narcolepsy	0.00187	0.00187	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HCRTR1—narcolepsy	0.00186	0.00186	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HCRTR2—narcolepsy	0.00186	0.00186	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00181	0.00181	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—P2RY11—narcolepsy	0.00179	0.00179	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—TRH—narcolepsy	0.00179	0.00179	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—HRH3—narcolepsy	0.00171	0.00171	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PENK—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—HTR2A—narcolepsy	0.00166	0.00166	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—TRH—narcolepsy	0.00162	0.00162	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00161	0.00161	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—TRH—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—HRH3—narcolepsy	0.00157	0.00157	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—TAC1—narcolepsy	0.00156	0.00156	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—NPS—narcolepsy	0.00156	0.00156	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HCRTR2—narcolepsy	0.00154	0.00154	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HCRTR1—narcolepsy	0.00154	0.00154	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HCRT—narcolepsy	0.00152	0.00152	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—P2RY11—narcolepsy	0.00149	0.00149	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—TRH—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—HRH3—narcolepsy	0.00142	0.00142	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—NPS—narcolepsy	0.00142	0.00142	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—TAC1—narcolepsy	0.00142	0.00142	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—HRH3—narcolepsy	0.00139	0.00139	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—HTR2A—narcolepsy	0.00138	0.00138	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HCRTR2—narcolepsy	0.00137	0.00137	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HCRTR1—narcolepsy	0.00137	0.00137	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PENK—narcolepsy	0.00136	0.00136	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—P2RY11—narcolepsy	0.00132	0.00132	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—TAC1—narcolepsy	0.0013	0.0013	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—NPS—narcolepsy	0.0013	0.0013	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HCRT—narcolepsy	0.00126	0.00126	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—HRH3—narcolepsy	0.00126	0.00126	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—HTR2A—narcolepsy	0.00123	0.00123	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—NPS—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—TAC1—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TRH—narcolepsy	0.00115	0.00115	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—TAC1—narcolepsy	0.00115	0.00115	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—NPS—narcolepsy	0.00115	0.00115	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PENK—narcolepsy	0.00113	0.00113	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CHKB—narcolepsy	0.00112	0.00112	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HCRT—narcolepsy	0.00112	0.00112	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—TAC1—narcolepsy	0.00105	0.00105	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—NPS—narcolepsy	0.00105	0.00105	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HRH3—narcolepsy	0.00101	0.00101	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PENK—narcolepsy	0.001	0.001	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TRH—narcolepsy	0.000958	0.000958	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—HTR2A—narcolepsy	0.000941	0.000941	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—HTR2A—narcolepsy	0.000854	0.000854	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TRH—narcolepsy	0.000851	0.000851	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HRH3—narcolepsy	0.00084	0.00084	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TAC1—narcolepsy	0.000839	0.000839	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NPS—narcolepsy	0.000839	0.000839	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—HTR2A—narcolepsy	0.000781	0.000781	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CPT1B—narcolepsy	0.000765	0.000765	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HRH3—narcolepsy	0.000746	0.000746	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—HTR2A—narcolepsy	0.000709	0.000709	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NPS—narcolepsy	0.000696	0.000696	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TAC1—narcolepsy	0.000696	0.000696	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—HTR2A—narcolepsy	0.000694	0.000694	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—HTR2A—narcolepsy	0.00063	0.00063	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TAC1—narcolepsy	0.000618	0.000618	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NPS—narcolepsy	0.000618	0.000618	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HTR2A—narcolepsy	0.000505	0.000505	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HTR2A—narcolepsy	0.000419	0.000419	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HTR2A—narcolepsy	0.000372	0.000372	CbGpPWpGaD
